J&J, Bayer Get $27 Million Xarelto Jury Verdict Thrown Out

Jan. 10, 2018, 3:10 PM

Johnson & Johnson and Bayer AG persuaded a Pennsylvania judge to throw out a jury verdict of more than $27 million over a woman’s injuries tied to the blood-thinning drug Xarelto.

Philadelphia Court of Common Pleas Judge Michael Erdos Jan. 9 concluded a procedural flaw in Lynn Hartman’s case required the verdict to be set aside, voiding the companies’ first trial loss over Xarelto, one of her lawyers said.

Johnson & Johnson and Bayer won the first three cases to come to trial in federal courts in Louisiana and Mississippi, after juries found the drug was safe and the companies...

To read the full article log in. To learn more about a subscription click here.